JUBILANT PHARMOVA Fact Sheet, JUBILANT PHARMOVA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA Fact Sheet    (JUBOL)


Check Out: Why Millions of Dollars are Getting Pumped into this Sector?


Here is the latest financial fact sheet of JUBILANT PHARMOVA . For more details, see the JUBILANT PHARMOVA quarterly results and JUBILANT PHARMOVA share price and chart. For a sector overview, read our pharmaceuticals sector report.

JUBILANT PHARMOVA Price History

Price Rs 592.0
Mkt Cap Rs m 94,294
Vol '000 6.0
P/E X 13.6
P/CF X 7.4
EPS (TTM) Rs 43.6
% ch % 1.0
No. of shares m 159.28
% ch week % -1.4
% ch 1-mth % -3.2
% ch 12-mth % -18.5
52 week H/L Rs 1,046.8/575.0
(As on Dec 2, 2021 03:36:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

JUBILANT PHARMOVA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
JUBILANT PHARMOVA  EQUITY SHARE DATA
High Rs8301,0398987271,047 
Low Rs294600617230251 
Sales per share (Unadj.) Rs358.9469.5572.0574.7559.1 
Earnings per share (Unadj.) Rs36.139.836.256.451.8 
Diluted earnings per shareRs36.139.836.256.451.8 
Cash flow per share (Unadj.) Rs54.465.959.585.480.1 
Dividends per share (Unadj.) Rs3.003.004.505.005.00 
Adj. dividends per shareRs3.003.004.505.005.00 
Avg Dividend yield %0.50.40.61.00.8 
Book value per share (Unadj.) Rs215.7256.6301.9351.8297.6 
Adj. book value per shareRs215.7256.6301.9351.8297.6 
Shares outstanding (eoy) m159.28159.28159.28159.28159.28 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x1.61.71.30.81.2 
Avg P/E ratio x15.620.620.98.512.5 
P/CF ratio (eoy) x10.312.412.75.68.1 
Price / Book Value ratio x2.63.22.51.42.2 
Dividend payout %8.37.512.48.99.7 
Avg Mkt Cap Rs m89,528130,531120,69176,220103,365 
No. of employees `000NANANANANA 
Total wages/salary Rs m12,30915,55919,26021,27721,728 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
JUBILANT PHARMOVA  INCOME DATA
Net Sales Rs m57,16574,77991,10891,54489,055 
Other income Rs m249400357474298 
Total revenues Rs m57,41475,17991,46692,01889,354 
Gross profit Rs m13,45315,18414,58819,12418,699 
Depreciation Rs m2,9144,1503,7094,6194,516 
Interest Rs m3,4112,8432,1982,8742,473 
Profit before tax Rs m7,3768,5919,03812,10512,008 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,6302,2473,2683,1233,764 
Profit after tax Rs m5,7466,3445,7708,9828,244 
Gross profit margin %23.520.316.020.921.0 
Effective tax rate %22.126.236.225.831.3 
Net profit margin %10.18.56.39.89.3 
JUBILANT PHARMOVA  BALANCE SHEET DATA
Current assets Rs m29,48131,89845,84850,38329,525 
Current liabilities Rs m16,84020,04720,89726,19010,488 
Net working cap to sales %22.115.827.426.421.4 
Current ratio x1.81.62.21.92.8 
Inventory Days Days10107713 
Debtors Days Days6455515234 
Net fixed assets Rs m59,50662,67467,34272,72158,109 
Share capital Rs m156156159159159 
"Free" reserves Rs m34,20040,70847,92955,88047,248 
Net worth Rs m34,35640,86448,08956,03947,407 
Long term debt Rs m35,05030,47842,42937,39725,640 
Total assets Rs m88,98794,572113,190123,10487,634 
Interest coverage x3.24.05.15.25.9 
Debt to equity ratio x1.00.70.90.70.5 
Sales to assets ratio x0.60.80.80.71.0 
Return on assets %10.39.77.09.612.2 
Return on equity %16.715.512.016.017.4 
Return on capital %15.516.012.416.019.8 
Exports to sales %00000 
Imports to sales %13.616.118.914.810.2 
Exports (fob) Rs m00000 
Imports (cif) Rs m7,76212,04417,22713,5159,117 
Fx inflow Rs m10,88114,40212,42215,51511,207 
Fx outflow Rs m7,76212,04417,22713,5159,117 
Net fx Rs m3,1192,358-4,8052,0002,090 
JUBILANT PHARMOVA  CASH FLOW
From Operations Rs m 12,685 13,032 11,215 15,429 17,843 
From Investments Rs m -4,504 -6,177 -10,118 -3,270 -7,390 
From Financial Activity Rs m -6,859 -9,011 6,574 -10,504 -17,094 
Net Cashflow Rs m 1,172 -2,123 7,612 2,254 -7,289 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 50.7%
Institution 24.2%
Non-Institution 25.2%
Total 100.0%
Free Float 49.3%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Bhartiagram, Jyotiba Phoolay Nagar, Gajraula - 244223
E-MAIL invstors@jubl.com WEB www.jubilantpharmova.com
TEL 05924-267200 FAX 05924-252352
SECTOR PHARMACEUTICALS GROUP Jubilant Bhartia
TR AGENT Alankit Assignments Ltd., 205-208 Anarkali Complex, Jhandewala Extension
AUDITOR K. N. Gutgutia & Co.
CHM: Shyam S. Bhartia COMP SEC: Lalit Jain YEAR OF INC: 1978 BSE CODE: 530019 FV (Rs): 1 DIV YIELD (%): 0.8

Read: JUBILANT PHARMOVA 2020-21 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   BACIL PHARMA  ALBERT DAVID  SMS PHARMA  CIAN HEALTHCARE  ADVANCED ENZYME TECHNOLOGIES  

Compare JUBILANT PHARMOVA With:   BACIL PHARMA  ALBERT DAVID  SMS PHARMA  CIAN HEALTHCARE  ADVANCED ENZYME TECHNOLOGIES  




Today's Market

Sensex Trades Higher, Nifty Above 17,250; Power Grid, IOC & Titan Among Top Gainers(10:30 am)

Asian share markets fell in early trade today hit by worries about the Omicron coronavirus variant and a hawkish tilt at the US Federal Reserve.

Views on news

JUBILANT PHARMOVA 2020-21 Annual Report Analysis (Annual Result Update)

Nov 8, 2021 | Updated on Nov 8, 2021

Here's an analysis of the annual report of JUBILANT PHARMOVA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT PHARMOVA . Also includes updates on the valuation of JUBILANT PHARMOVA .

Jubilant Pharmova Drops 6% on Weak March Quarter Numbers (Views On News)

Jun 8, 2021

Here's a rundown on the latest quarterly results of Jubilant Pharmova.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA - PANACEA BIOTECH COMPARISON

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS